Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Shikonin as a therapeutic agent in renal cell carcinoma: insights from TEK-related causal association with glaucoma

Submitted by Frida Mäkelä on Wed, 08/20/2025 - 09:46
  • Read more about Shikonin as a therapeutic agent in renal cell carcinoma: insights from TEK-related causal association with glaucoma

Exploring the Association Between Multidimensional Dietary Patterns and Non-Scarring Hair Loss Using Mendelian Randomization

Submitted by Frida Mäkelä on Sun, 08/17/2025 - 15:31
  • Read more about Exploring the Association Between Multidimensional Dietary Patterns and Non-Scarring Hair Loss Using Mendelian Randomization

From Hypothyroidism to Coronary Heart Disease: Unraveling the Lipid Profile Link: A Mendelian Randomization Study

Submitted by Frida Mäkelä on Sun, 08/17/2025 - 15:26
  • Read more about From Hypothyroidism to Coronary Heart Disease: Unraveling the Lipid Profile Link: A Mendelian Randomization Study

Exploring the Causal Relationships and Underlying Mechanisms of Genetically Linked Immune Cells with Hemorrhagic Stroke

Submitted by Frida Mäkelä on Sun, 08/17/2025 - 15:20
  • Read more about Exploring the Causal Relationships and Underlying Mechanisms of Genetically Linked Immune Cells with Hemorrhagic Stroke

Dissecting causal networks of inflammatory factors and metabolites in heart failure: A mediation Mendelian randomization study

Submitted by Frida Mäkelä on Sun, 08/17/2025 - 15:13
  • Read more about Dissecting causal networks of inflammatory factors and metabolites in heart failure: A mediation Mendelian randomization study

Mendelian randomization revealed a one-way causal association between increased Isovalerylcarnitine (C5) levels and the risk of idiopathic pulmonary fibrosis

Submitted by Frida Mäkelä on Sun, 08/17/2025 - 15:06
  • Read more about Mendelian randomization revealed a one-way causal association between increased Isovalerylcarnitine (C5) levels and the risk of idiopathic pulmonary fibrosis

Statins and hemorrhagic stroke: New insight from a Mendelian randomization study

Submitted by Frida Mäkelä on Fri, 08/15/2025 - 12:20
  • Read more about Statins and hemorrhagic stroke: New insight from a Mendelian randomization study

Cardiorenal Interorgan Assessment via a Novel Clustering Method Using Dynamic Time Warping on Electrocardiogram: Model Development and Validation Study

Submitted by Frida Mäkelä on Fri, 08/15/2025 - 12:02
  • Read more about Cardiorenal Interorgan Assessment via a Novel Clustering Method Using Dynamic Time Warping on Electrocardiogram: Model Development and Validation Study

Genetic insights into lipid traits and atherosclerosis risk: a mendelian randomization and polygenic risk score analysis

Submitted by Frida Mäkelä on Fri, 08/15/2025 - 11:56
  • Read more about Genetic insights into lipid traits and atherosclerosis risk: a mendelian randomization and polygenic risk score analysis

Unraveling Genetic Causality Between Type 2 Diabetes Mellitus and Hemiplegia Based on Mendelian Randomization

Submitted by Frida Mäkelä on Fri, 08/15/2025 - 11:50
  • Read more about Unraveling Genetic Causality Between Type 2 Diabetes Mellitus and Hemiplegia Based on Mendelian Randomization

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 84
  • Page 85
  • Page 86
  • Page 87
  • Current page 88
  • Page 89
  • Page 90
  • Page 91
  • Page 92
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement